Yoon Jun Kim Selected Research

adefovir

1/2020	Long-term Nucleotide Analogue Treatment Has Higher Levels of Renal Toxicities than Does Entecavir in Patients with Chronic Hepatitis B.
1/2019	Monotherapy with tenofovir disoproxil fumarate for adefovir-resistant vs. entecavir-resistant chronic hepatitis B: A 5-year clinical trial.
3/2017	Tenofovir has inferior efficacy in adefovir-experienced chronic hepatitis B patients compared to nucleos(t)ide-naïve patients.
1/2016	Tenofovir monotherapy versus tenofovir and entecavir combination therapy in adefovir-resistant chronic hepatitis B patients with multiple drug failure: results of a randomised trial.
6/2015	Comparison of the efficacies of entecavir 0.5 and 1.0 mg combined with adefovir in patients with chronic hepatitis B who had failed on prior nucleos(t)ide analogue treatments.
12/2013	Efficacy of adefovir-based combination therapy for patients with Lamivudine- and entecavir-resistant chronic hepatitis B virus infection.
5/2013	The efficacy of adefovir plus entecavir combination therapy in patients with chronic hepatitis B refractory to both lamivudine and adefovir.
7/2011	Add-on adefovir is superior to a switch to entecavir as rescue therapy for Lamivudine-resistant chronic hepatitis B.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Yoon Jun Kim Research Topics

Disease

124	Hepatocellular Carcinoma (Hepatoma) 10/2022 - 04/2003
66	Neoplasms (Cancer) 10/2022 - 06/2003
50	Chronic Hepatitis B 10/2022 - 04/2003
34	Infections 10/2022 - 04/2003
25	Fibrosis (Cirrhosis) 01/2022 - 03/2007
24	Hepatitis B 01/2022 - 10/2003
16	Liver Cirrhosis (Hepatic Cirrhosis) 01/2022 - 03/2007
13	Neoplasm Metastasis (Metastasis) 01/2021 - 11/2010
10	Non-alcoholic Fatty Liver Disease 01/2020 - 07/2010
9	Liver Neoplasms (Liver Cancer) 02/2022 - 01/2014
8	Liver Diseases (Liver Disease) 01/2022 - 08/2008
8	Chronic Hepatitis C 11/2021 - 12/2015
8	Hepatitis 09/2017 - 01/2011
7	Hypertension (High Blood Pressure) 01/2022 - 08/2012
6	Carcinogenesis 11/2018 - 12/2010
6	Hypoxia (Hypoxemia) 12/2016 - 09/2010
5	Disease Progression 05/2022 - 07/2005
5	Ascites 01/2019 - 03/2007
4	Hemorrhage 01/2022 - 03/2014
4	Peritonitis 01/2021 - 03/2010
4	End Stage Liver Disease 01/2021 - 03/2014
4	Portal Hypertension 05/2015 - 03/2010
3	Fatty Liver 01/2022 - 06/2005
3	Viremia 01/2020 - 11/2012
2	Inflammation (Inflammations) 05/2022 - 09/2014
2	Diabetes Mellitus 01/2022 - 07/2010
2	Thrombosis (Thrombus) 01/2022 - 10/2011

Drug/Important Bio-Agent (IBA)

27	Antiviral Agents (Antivirals)IBA 10/2022 - 07/2005
26	Sorafenib (BAY 43-9006)FDA Link 10/2022 - 01/2014
24	DNA (Deoxyribonucleic Acid)IBA 01/2022 - 12/2009
20	Tenofovir (Viread)FDA Link 05/2022 - 11/2014
18	entecavir FDA Link 05/2022 - 07/2011
14	Hepatitis B e AntigensIBA 01/2022 - 07/2008
13	Pharmaceutical PreparationsIBA 01/2022 - 01/2011
13	Hepatitis B Surface Antigens (HBsAg)FDA Link 11/2021 - 06/2005
12	alpha-Fetoproteins (alpha-Fetoprotein)IBA 03/2022 - 01/2011
8	Alanine Transaminase (SGPT)IBA 03/2022 - 07/2010
8	adefovirIBA 01/2020 - 07/2011
7	Aspartate Aminotransferases (Aspartate Transaminase)IBA 05/2022 - 07/2010
7	BilirubinIBA 03/2022 - 12/2012
7	Lamivudine (Epivir)FDA Link 02/2015 - 07/2011
6	Fetal Proteins (Fetoprotein)IBA 05/2022 - 08/2013
6	AntigensIBA 01/2022 - 11/2011
6	Proteins (Proteins, Gene)FDA Link 09/2020 - 12/2010
6	Biomarkers (Surrogate Marker)IBA 07/2020 - 08/2012
6	MicroRNAs (MicroRNA)IBA 11/2014 - 01/2012
5	AlbuminsIBA 01/2022 - 03/2010
5	Yttrium-90IBA 05/2021 - 01/2018
5	InterferonsIBA 01/2020 - 09/2012
5	lipoarabinomannan (LAM)IBA 02/2015 - 07/2011
4	thiamine triphosphorate (TTP)IBA 03/2022 - 01/2014
4	Vitamin K FDA Link 09/2020 - 10/2011
4	EnzymesIBA 01/2019 - 03/2011
4	Ethanol (Ethyl Alcohol)IBA 08/2016 - 12/2003
3	tenofovir alafenamideIBA 01/2022 - 12/2021
3	maleic acid (maleate)IBA 04/2021 - 01/2019
3	((1- ((2- amino- 9H- purin- 9- yl)methyl)cyclopropyl)oxy)methylphosphonic acid dipivoxylIBA 04/2021 - 01/2019
3	NucleotidesIBA 01/2021 - 01/2019
3	Anti-Bacterial Agents (Antibiotics)IBA 01/2021 - 03/2010
3	Tumor Biomarkers (Tumor Markers)IBA 11/2019 - 10/2011
3	bromopyruvateIBA 03/2019 - 02/2012
3	HexokinaseIBA 03/2019 - 02/2012
3	Ursodeoxycholic Acid (Urso)FDA LinkGeneric 01/2019 - 06/2011
3	VaccinesIBA 09/2017 - 12/2015
3	Insulin-Like Growth Factor I (IGF-1)IBA 01/2017 - 08/2013
3	Protein Disulfide-IsomerasesIBA 01/2017 - 02/2012
2	lenvatinibIBA 10/2022 - 03/2022
2	HDL CholesterolIBA 01/2022 - 08/2012
2	CholesterolIBA 01/2022 - 01/2020
2	Aspirin (Acetylsalicylic Acid)FDA LinkGeneric 01/2022 - 11/2017
2	glecaprevir and pibrentasvirIBA 11/2021 - 01/2020
2	NivolumabIBA 01/2021 - 01/2020
2	regorafenibIBA 01/2020 - 01/2019
2	TabletsIBA 01/2020 - 11/2016
2	Serum AlbuminIBA 01/2020 - 03/2014
2	Biological ProductsIBA 11/2019 - 04/2008
2	gadolinium ethoxybenzyl DTPA FDA Link 06/2019 - 05/2015
2	CytokinesIBA 05/2019 - 01/2019
2	RNA (Ribonucleic Acid)IBA 12/2018 - 01/2011
2	Phosphotransferases (Kinase)IBA 12/2018 - 12/2015
2	Reactive Oxygen Species (Oxygen Radicals)IBA 11/2018 - 02/2015
2	Protein Kinases (Protein Kinase)IBA 11/2018 - 08/2010
2	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 06/2018 - 01/2016
2	vesatolimodIBA 01/2018 - 08/2015
2	Messenger RNA (mRNA)IBA 10/2017 - 11/2012
2	Cytidine Triphosphate (CTP)IBA 01/2017 - 03/2007
2	acarboxyprothrombin (PIVKA)IBA 01/2017 - 10/2011
2	Insulin (Novolin)FDA Link 01/2017 - 01/2014

Therapy/Procedure

47	Therapeutics 03/2022 - 12/2003
23	Radiofrequency Ablation 12/2021 - 01/2011
11	Liver Transplantation 09/2020 - 12/2013
9	Electrodes (Electrode) 12/2021 - 08/2013
6	Radiotherapy 02/2022 - 11/2010
6	Drug Therapy (Chemotherapy) 07/2020 - 11/2012
5	Immunotherapy 05/2019 - 06/2015
4	Transplantation 01/2020 - 12/2013
3	Microspheres (Microsphere) 05/2021 - 01/2019
3	Aftercare (After-Treatment) 03/2015 - 10/2011
2	Surgical Portasystemic Shunt (Portosystemic Shunt) 11/2018 - 03/2014
2	Transjugular Intrahepatic Portasystemic Shunt 11/2018 - 03/2014